Literature DB >> 17489715

Psychotropic prescriptions in a sample including both healthy and mood and disruptive disordered preschoolers: relationships to diagnosis, impairment, prescriber type, and assessment methods.

Joan L Luby1, Melissa Meade Stalets, Andy C Belden.   

Abstract

OBJECTIVE: Epidemiological data has shown that psychotropic medications are being prescribed to preschoolers at increasing rates. The diagnostic context and functional impairment of these preschoolers remains unknown. This investigation aimed to address these questions in a sample of preschoolers who were either without symptoms (healthy) or with mood and disruptive disorders by assessing them using a structured diagnostic interview and measure of impairment.
METHOD: Preschoolers aged 3.0 to 5.11 without symptoms and those with symptoms of mood and disruptive disorders were recruited from primary care and daycare sites in the St. Louis area to participate in a psychiatric evaluation that included information about psychotropic prescriptions from community practitioners.
RESULTS: Seven percent of preschoolers (n = 19) out of a total sample of n = 267 were prescribed psychotropic medications. Fifty-two percent of preschoolers in the total sample met criteria for an Axis I psychiatric disorder. Presence of an Axis I disorder was significantly related to psychotropic prescription (p < 0.01). Among preschoolers who met criteria for an Axis I disorder 12% received psychotropics (Dx/Rx group). The Dx/Rx group was more impaired than those with a diagnosis who were not prescribed psychotropics (p < 0.001). Among preschoolers taking psychotropic medications, two failed to meet criteria for any Axis I disorder.
CONCLUSION: In this sample, most psychotropic medications were prescribed for impaired preschoolers with an Axis I diagnosis. These findings shed some light on the prescribing trends among mood and disruptive disordered preschoolers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489715     DOI: 10.1089/cap.2007.0023

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  7 in total

1.  Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics.

Authors:  Donna R Halloran; Jason Swindle; Steve K Takemoto; Mark A Schnitzler
Journal:  Clin Pediatr (Phila)       Date:  2010-01-28       Impact factor: 1.168

2.  Disrupted amygdala reactivity in depressed 4- to 6-year-old children.

Authors:  Michael S Gaffrey; Deanna M Barch; Janet Singer; Rivfka Shenoy; Joan L Luby
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-05-22       Impact factor: 8.829

3.  Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.

Authors:  Marcia A Kearns; Kristin M Hawley
Journal:  J Psychiatr Pract       Date:  2014-11       Impact factor: 1.325

4.  The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems.

Authors:  Ann F Garland; Lauren Brookman-Frazee; Emily Gray
Journal:  Community Ment Health J       Date:  2012-07-06

5.  Psychotropic drug use among preschool children in the Medicaid program from 36 states.

Authors:  Lauren D Garfield; Derek S Brown; Benjamin T Allaire; Raven E Ross; Ginger E Nicol; Ramesh Raghavan
Journal:  Am J Public Health       Date:  2015-01-20       Impact factor: 9.308

6.  Treating our youngest patients: psychotropic medications in early childhood.

Authors:  Catherine Madden; Benjamin Black; Debra Willsie
Journal:  Mo Med       Date:  2014 May-Jun

7.  Enhancing the primary care pediatrician's role in managing psychosocial issues: a cross sectional study of pediatricians and parents in Israel.

Authors:  Hava Gadassi; Inbal Millo David; Maya Yaari; Eitan Kerem; Manuel Katz; Basil Porter; Chen Stein-Zamir; Zachi Grossman
Journal:  Isr J Health Policy Res       Date:  2022-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.